In order to investigate the effect of fenfluramine on hormonal and metabolic changes with exercise, five normal volunteers have been studied during and after 20 minutes of steady exercise on a bicycle ergometer after injection of fenfluramine (20 mg intravenously). Fenfluramine abolished the rise of plasma human growth hormone (HGH) which occurred in control investigations. Fenfluramine also affected plasma insulin, blood glucose, and ketone body levels.
Introduction
Fenfluramine (Ponderax), a derivative of amphetamine, has been reported to cause weight loss in man (Duncan et al., 1965; Traherne, 1965; Munro et al., 1966) and animals (Alphin et al., 1964; Le Douarec and Schmitt, 1964) and is used in the management of obesity. Its mode of action is, however, still uncertain and has been attributed to either a direct metabolic effect of fenfluramine on fat and carbohydrate metabolism (Butterfield and Whichelow, 1968; Dannenburg and Kardian, 1969; Pawan, 1969) or a depressant action on centres in the central nervous system regulating appetite and food intake (Foxwell et al., 1968) . Experimental observations on animals have indicated the hypothalamus as a possible site for the action of the drug (Anand, 1971; Anand and Blundell, 1971) .
The hypothalamus influences the secretion of hormones of the anterior pituitary, including growth hormone, via intermediary neurohormones (McCann, 1970) . It is therefore possible that alteration of release of growth hormone may occur with drugs affecting the hypothalamus. Should such changes occur they would provide evidence for the hypothalamus or its connexions being a major site of action of the drug. Preliminary observations in normal human subjects showed that fenfluramine caused a depression in the level of plasma human growth hormone (HGH) when subjects were at rest. Resting levels of HGH are, however, low (2-6 sLU/ml) and, as exercise is a situation known to stimulate the release of HGH (Hunter and Greenwood, 1964; , we have studied the effect of fenfluramine on the release of HGH and insulin in relation to the metabolic response to exercise in normal volunteers.
Hypothalamic dysfunction may result in acromegaly in some patients. In acromegaly the hypersecretion of HGH is not always autonomous (Cryer and Daughaday, 1969; Lawrence et al., 1970) and the level may rise with an appropriate stimulus such as exercise (Johnson and Rennie, 1973) . We have, therefore, studied a group of subjects with acromegaly when given fenfluramine. In one subject this was given before exercise. Our observations in normal subjects and patients with acromegaly indicate the suppressive action of fenfluramine on HGH release. S.E. of mean) and mean weights of 72-3 kg (± 2-3 kg S.E. of mean) were studied. Their mean resting plasma HGH level after overnight fasting was 65-5 ,tU/ml (± 14-7 LU S.E. of mean) and they were studied during investigation for acromegaly when no other therapy was being given. On the day of the investigation the patient had fasted overnight and rested in bed. A catheter was placed in an antecubital vein and intravenous fenfluramine (20 mg) was administered. Venous samples were taken before the injection, and 5, 10, 20, 30, 45, 60, and 90 min later.
Methods
Exercise.-One male patient with acromegaly (aged 21 years), height 174 cm and weight 76 kg, was studied on two separate occasions in the same manner as described above. His resting plasma HGH level after overnight fasting was 76-74 ,tU/ml and no treatment or replacement therapy had been started.
LABORATORY PROCEDURE
In all investigations each blood sample was divided into two parts. Five ml was deproteinized by addition to 1000 perchloric acid. The remainder was heparinized and the plasma separated by centrifugation. All specimens were then stored in ice. The deproteinized samples were analysed for glucose (Bergmeyer and Bernt, 1963) , lactate and pyruvate (Hohorst et al., 1959) , acetoacetate and 3-hydroxybutyrate (Williamson et al., 1962) .
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The plasma sample was analysed for free fatty acids by a colorimetric method after chloroform extraction (Itaya and Ui, 1965) , HGH was analysed by a radioimmunoassay using two antibodies (Morgan and Lazarow, 1963) , and immunoreactive insulin by a charcoal immunoassay (Hunter, 1969; Hunter and Ganguli, 1971 Glucose.-Therewas no difference in the restingconcentrations of blood glucose on the two occasions ( fig. 2 ). Exercise caused a fall in the concentrations at 5 min in the control investigation, but with fenfluramine the fall was more pronounced after 15 min of exercise when the concentration was significantly different from that of the control study (P < 0-05). Although the levels during recovery were not statistically different at any one time, on the control occasion the concentrations were consistently higher and returned to the resting level 15 min after exercise, whereas with fenfluramine the concentrations remained below the resting level throughout the remaining period of investigation.
Free Fatty Acids.-Resting plasma free fatty acid concentrations were not significantly different on the two occasions ( fig. 3) free fatty acids with the maxima at the end of exercise. In the control investigation the concentrations returned to resting levels by the end of the investigation, whereas with fenfluramine they remained higher in the period after exercise although they were only significantly different from that of the control study at 30 min after exercise (P < 0 01).
Ketone Bodies.-Resting levels of total ketone bodies (acetoacetate plus 3-hydroxybutyrate) were not statistically different at rest (fig. 3 ). Exercise caused a small fall in concentrations on the control occasion, but with fenfluramine the fall was more pronounced (P < 0-01). The levels rose after the initial fall, both in the remaining part of exercise and for 15 a-glycerophosphate in adipose tissue and decreases fat synthesis sma HGH (>units/ml, means + S.E. of mean) (Wilson and Galton, 1971) . cts after two periods of 20 min exercise.
The secretion of HGH from the anterior pituitary is influenced by the hypothalamus through an intermediary neurohormone system which is probably controlled by adrenergic mechanisms (Fuxe and Hokfelt, 1969; Wurtman, 1970; Forhman, 1972) .
NJECTION OF FENFLURAMINE ON PATIENTS WITH Some drugs, such as levodopa (Eddy et al., 1971; Kansal et al., 1972) and amphetamine (Besser et al., 1969) , cause increased ramine caused the concentration of HGH to noradrenaline synthesis or turnover in brain and stimulate the Id 28% at 20, 30, and 45 min after the injection release of HGH probably by stimulating hypothalamic activity. :0 01) ( fig. 5 ). The concentration returned to
The cause of HGH release with exercise may therefore result 60 min after the injection. from increased noradrenaline in the hypothalamus. Fenfluramine, however, depletes cerebral amines and decreases their concentration particularly in the hypothalamus (Costa et al., 1971; Ziance et al., 1972) , and it may, therefore, interfere with HGH release by affecting the adrenergic activity of the hypoExercise (i) thalamus. This mechanism may also explain the failure of the fall in glucose concentrations to stimulate HGH production in the investigation with fenfluramine, for hypoglycaemia also i'Control acts via its effect on adrenergic mechanisms in the brain (Blackard and Heidingsfelder, 1968 (Cryer and Daughaday 1969; Lawrence et al., 1970; Johnson and Rennie, 1973) , indicating that the hypothalamic-pituitary axis is still active in some patients. In our patients fenfluramine caused a depression in the concentration of HGH at rest and the rise in HGH during exercise in one patient was attenuated by the drug. These observations suggest that the drug may be of value in the medical management of acromegaly. Exercise.-On the control occasion exercise caused a progressive rise of HGH to a maximum of 32% above the resting level, whereas with fenfluramine the maximum was 170', above resting level ( fig. 5 ).
Introduction
If thyrotoxic patients are given a conventional course of treatment with antithyroid drugs, about 30-50% experience a prolonged remission and the remainder relapse (Hershman et al., 1966; Alexander et al., 1973) . It has usually been thought that antithyroid drugs do not fundamentally affect the course of the disease, but merely inhibit thyroid hormone production until a natural remission occurs. If this is true it would be expected that the rate and frequency of remission of thyrotoxicosis would be independent of the drug used-whether, for example, a patient was treated with carbimazole or propranolol.
In this study remission occurred in several patients treated with propranolol alone in spite of the drug having no direct in-vivo effect on thyroid function (Hadden et al., 1969; Biran and Tal, 1972) . Although it has been proposed that propranolol might be suitable as a definitive form of therapy for mild cases of thyrotoxicosis (Pimstone et al., 1969) our evidence suggests that this drug is not an acceptable alternative to conventional antithyroid drug therapy.
Patients and Methods
Twenty-eight patients were treated with propranolol. Thyrotoxicosis was confirmed by the presence of clinical features of the disease, a free thyroxine index (Clark and Horn, 1965) greater than 8, and in all patients the 20-minute 32I uptake (Alexander et al., 1969) 
